Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
113 Views
Favorite
0
Like
Facebook
Tweet
Federal Forum
(1-067) Impact of Dolutegravir versus Bictegravir on Metabolic and Renal Outcomes
Sunday, December 4, 2022
3:30 PM – 5:00 PM
Location: Bayside A, Level 1
Category:
Evaluative Study
Topic:
Infectious Diseases/HIV
Co-Author(s):
Andrew Franck, Bhaumik Jivan
Primary Author(s)
Sarah M. West, n/a
Florida